Minovivax (Minoxidil)

Minoxidil opens ATP‑sensitive potassium channels in the cells surrounding hair follicles, leading to vasodilation and improved blood flow. The enhanced circulation supplies more oxygen and nutrients, which prolongs the anagen (growth) phase of the hair cycle and stimulates follicular enlargement, resulting in new hair shaft formation.

The specific dose of Minovivax is determined by the prescribing healthcare professional. Typically, the product is applied to the affected scalp area once or twice daily, using the amount recommended on the label or by the clinician, and the exact volume should not exceed the guidance provided.

Safety data for minoxidil use during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before starting Minovivax, and use only if the benefits outweigh any possible concerns.

To order Minovivax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Minovivax (minoxidil) is a topical potassium channel opener, distinct from oral finasteride, which is a 5‑α‑reductase inhibitor. While finasteride works systemically to reduce dihydrotestosterone, minoxidil acts locally to enhance follicular blood flow. Both can be effective, but they target different pathways and may be used alone or together under medical supervision.

Minovivax should be stored at room temperature below 25 °C, in its original container, protected from direct light and moisture. Keep the product out of reach of children and avoid freezing. If the solution changes color or becomes cloudy, discard it and obtain a new supply.

Apply Minovivax to a clean, dry scalp using the supplied applicator or a dropper. Distribute the recommended amount evenly over the affected area, gently massaging it into the skin. Wash your hands after application and avoid contact with eyes, nose or mouth.

Serious risks, though rare, include severe allergic reactions such as swelling, rash, or difficulty breathing, and systemic hypotension that can cause dizziness or fainting if the drug is absorbed in large amounts. Users should seek immediate medical attention if any of these symptoms occur.

Minovivax should not be used by individuals with known hypersensitivity to minoxidil or any of the formulation excipients. It is also contraindicated in people with severe scalp irritation, open wounds, or infections at the application site, and should be avoided by those advised against topical vasodilators by their physician.